If cost, coverage, or access is a barrier (our getting-started guide covers the standard routes), or you're curious about the next generation of GLP-1 and dual- or triple-agonist drugs still in development (see what's in the pipeline), a clinical trial can be a real option. Participants often receive the study medication and close medical monitoring at no cost, while helping produce the evidence that gets these treatments approved. Trials suit some people and not others, so it helps to understand how they work before you rule one in or out.
Why consider a trial, and the trade-offs
A trial can give you access to investigational drugs that aren't available yet. It's the only legitimate way to receive them; the "research peptides" sold online are something else entirely (see our guide on research peptides and GLP-1 medications). Some trials also provide approved drugs at no cost. You get regular monitoring by the study team, and you contribute directly to research.
The trade-offs, stated plainly:
- You might get a placebo. Many trials randomly assign you to the drug or an inactive comparator, and you usually won't know which. Some trials guarantee everyone eventually gets the active drug and some don't, so check.
- It takes time. Trials involve scheduled visits, tests, logs, and sometimes travel.
- Eligibility is strict. Trials screen on age, BMI, other conditions, current medications, and more. Being turned away from one doesn't mean you won't qualify for another.
- It's structured. You follow the protocol, not a personalized plan, though you can leave at any time, for any reason.
Knowing these up front makes it easier to judge whether a particular study fits your life.
Where to search
- ClinicalTrials.gov (external link) is the main government-run registry of trials in the U.S. and worldwide. Search by condition (for example "obesity" or "weight loss") and drug name, and filter by "Recruiting" status and your location. Each listing shows eligibility, phase, locations, and contact details.
- Academic medical centers and universities near you often list their own recruiting studies.
- Drug manufacturers run trial-finder sites for their own pipeline drugs; Novo Nordisk's is novonordisk-trials.com, for example.
- Patient advocacy organizations sometimes maintain trial matchers and can point you to reputable studies.
Start broad on ClinicalTrials.gov, then narrow by what's recruiting near you.
How to read a listing
A few fields matter most:
- Recruitment status. Look for "Recruiting." A study marked "Enrolling by invitation" is choosing participants from a group the researchers picked in advance, so it generally isn't open to the public even if you meet the criteria.
- Eligibility criteria. The inclusion and exclusion list decides whether you can join. Read it before you get attached to a study.
- Phase. Per FDA, Phase 1 tests safety and dosage in 20 to 100 people; Phase 2 looks at efficacy and side effects in up to several hundred; Phase 3 tests efficacy and monitors adverse reactions in 300 to 3,000. Later phases generally have more established safety data.
- Study design. Check whether it's randomized and placebo-controlled, and whether there's an open-label extension where participants can get the active drug afterward.
- Locations and contacts. These are the sites running the study and who to call or email to start.
Screening and informed consent
If a study looks like a fit, you contact the site and go through screening: questions, and usually a visit with tests to confirm you meet the criteria. Not everyone who screens gets in.
Before anything begins, you go through informed consent. The team walks you through the purpose, procedures, risks, benefits, and your rights, and you get the document to read and keep. This is your chance to ask everything. Two rights to hold onto: participation is voluntary, and you can withdraw at any time without losing your regular medical care.
Questions worth asking the study coordinator
- What are my chances of receiving the active drug versus placebo?
- If I'm on placebo, will I get the active drug later (is there an open-label extension)?
- What's the visit schedule, and how long is the commitment?
- Are visits, tests, and the medication free? Is travel or time reimbursed?
- What happens when the trial ends? Can I keep getting the drug?
- Who do I contact if I have side effects or concerns?
It's also worth telling your own doctor you're considering a trial, so it fits with the rest of your care.
Red flags: how to spot a fake
Legitimate trials do not ask you to pay to participate. Be wary of anything that:
- Charges a fee to enroll or "reserve a spot."
- Guarantees results or a specific outcome.
- Skips informed consent or rushes you to sign.
- Recruits only through social-media DMs with no verifiable site or ClinicalTrials.gov listing.
If you can't find the study on ClinicalTrials.gov or verify the institution running it, treat it as marketing until proven otherwise.
This is general education, not medical advice. Whether a specific trial is right for you depends on your health and history, so discuss it with your prescriber.